Financial results - BUSINESS PHARMA CONSULTING SRL

Financial Summary - Business Pharma Consulting Srl
Unique identification code: 37611216
Registration number: J2017002396239
Nace: 4711
Sales - Ron
174.623
Net Profit - Ron
46.173
Employees
10
Open Account
Company Business Pharma Consulting Srl with Fiscal Code 37611216 recorded a turnover of 2024 of 174.623, with a net profit of 46.173 and having an average number of employees of 10. The company operates in the field of CAEN Ver.3: Comerţ cu amănuntul nespecializat, cu vânzare predominantă de produse alimentare, băuturi şi tutun; CAEN Ver.2: Comert cu amanuntul in magazine nespecializate, cu vanzare predominanta de produse alimentare, bauturi si tutun; having the NACE code 4711.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Business Pharma Consulting Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 0 0 0 51.296 94.500 174.623
Total Income - EUR - - - - 0 0 0 51.296 94.500 174.623
Total Expenses - EUR - - - - 0 0 0 19.278 26.098 124.006
Gross Profit/Loss - EUR - - - - 0 0 0 32.018 68.402 50.618
Net Profit/Loss - EUR - - - - 0 0 0 31.516 67.476 46.173
Employees - - - - 0 0 0 3 3 10
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 85.8%, from 94.500 euro in the year 2023, to 174.623 euro in 2024. The Net Profit decreased by -20.926 euro, from 67.476 euro in 2023, to 46.173 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Business Pharma Consulting Srl

Rating financiar

Financial Rating -
BUSINESS PHARMA CONSULTING SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Business Pharma Consulting Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Business Pharma Consulting Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Business Pharma Consulting Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Business Pharma Consulting Srl - CUI 37611216

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 19 19 18 18 18 21.569
Current Assets - - - - 2.460 2.413 2.360 35.802 82.961 77.841
Inventories - - - - 0 0 0 0 0 1.531
Receivables - - - - 0 0 0 19.074 67.459 67.619
Cash - - - - 2.460 2.413 2.360 16.728 15.502 8.691
Shareholders Funds - - - - 2.479 2.432 2.378 33.901 67.525 46.221
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 0 0 0 1.920 15.455 53.190
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4711 - 4711"
CAEN Financial Year 4711
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 77.841 euro in 2024 which includes Inventories of 1.531 euro, Receivables of 67.619 euro and cash availability of 8.691 euro.
The company's Equity was valued at 46.221 euro, while total Liabilities amounted to 53.190 euro. Equity decreased by -20.926 euro, from 67.525 euro in 2023, to 46.221 in 2024.

Risk Reports Prices

Reviews - Business Pharma Consulting Srl

Comments - Business Pharma Consulting Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.